Animal models of drug withdrawal symptoms

Psychopharmacology

Volumn 101, Issue 3, 1990, Pages 292-309

  Emmett Oglesby, M W ^a   Mathis, D A ^a   Moon, R T Y ^a   Lal, H ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Anxiety; Benzodiazepines; Cocaine; Diazepam; Discriminative stimulus; Drug dependence; Drug discrimination; Drug withdrawal; Drugs of abuse; Ethanol; Withdrawal signs; Withdrawal symptoms

Indexed keywords

ALCOHOL; COCAINE; DIAZEPAM; MORPHINE; NICOTINE; PENTETRAZOLE; PHENCYCLIDINE; TETRAHYDROCANNABINOL;

ANIMAL; ANIMAL MODEL; ANXIETY; DRUG ABUSE; DRUG DISCRIMINATION; DRUG TOLERANCE; DRUG WITHDRAWAL; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMAL; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; ANXIETY; CONDITIONING, OPERANT; MODELS, PSYCHOLOGICAL; NARCOTICS; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025372444     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244046     Document Type: Review

References (169)

1. Behavioral sitmulation induced by ethanol withdrawal
2. Drugs as discriminable events in humans
3. Does the pentylenetetrazole (PTZ) cue reflect PTZ-induced kindling or PTZ-induced anxiogenesis?
4. Analyzing mechanism of hallucinogenic drug action with drug discrimination procedures
5. Cocaine precipitation of panic disorder
6. Drug discrimination in pentylenetetrazol-trained baboons: generalization to buspirone and β-carboline-3-carboxylic acid ethyl ester but not lorazepam or pentobarbital
7. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor
8. Behavioral studies of tolerance and dependence
9. Continuous-access phencyclidine self-administration by rhesus monkeys leading to physical dependence
10. Time dependent pentylenetetrazol-like cues subsequent to diazepam administration
11. Dependence on tetrahydrocannabinol in rhesus monkeys
12. Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome
13. Modulation of the discriminative stimulus produced by pentylenetetrazole by centrally administered drugs
14. Clonidine in alcohol withdrawal
15. Enhancement of alcohol withdrawal convulsions in mice by haloperidol
16. An azido analogue of the benzodiazepine antagonist Ro 15-1788 (Ro 15-4513) behaves as a partial inverse benzodiazepine agonist
17. Heroin reward is dependent on a dopaminergic function
18. Withdrawal reaction after long-term therapeutic use of benzodiazepines
19. Cocaine withdrawal produces behavioral disruptions in rat
20. Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects
21. An experimental paradigm for studying the discriminative stimulus properties of drugs in humans
22. The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans
23. The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans
24. Clonidine and naltrexone. A safe, effective and rapid treatment of abrupt withdrawal from methadone therapy
25. Discriminative stimulus properties of narcotic analgesic drugs
26. Some properties of drugs as physiological signals: the FR procedure and signal detection theory
27. Drug discrimination: behavioral, pharmacological, and molecular mechanisms of discriminative drug effects
28. Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments
29. Endogenous ligands for benzodiazepine recognition sites
30. Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats
31. The effects of chronic administration of trans-delta-9-tetrahydrocannabinol on behavior and the cardiovascular system of dogs
32. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors
33. Increased tolerance and withdrawal phenomena in chronic morphinism. A review of the literature
34. The pentylenetetrazol model of anxiety detects withdrawal from diazepam in rats
35. Anxiogenic aspects of diazepam withdrawal can be detected in animals
36. Discriminative stimulus properties of cocaine
37. Bioassay of subjective effects associated with benzodiazepine withdrawal in animals: a novel direction in dependence research
38. Diazepam tolerance and withdrawal assessed in an animal model of subjective drug effects
39. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol
40. A relationship between withdrawal and tolerance to the discriminative stimulus properties of cocaine
41. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions
42. The neurochemistry of anxiety
43. Behavioral pharmacology of benzodiazepines
44. Tolerance to the behavioral actions of benzodiazepines
45. Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety
46. Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions?
47. Anxiogenic action of a convulsant benzodiazepine: reversal by chlordiazepoxide
48. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat
49. The behavioral pharmacology of cocaine in humans
50. Cocaine self-administration in humans
51. A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans
52. Schedule-controlled behavior in the morphine-dependent rat
53. Morphine, saline and naltrexone discrimination in morphine-treated pigeons
54. An abstinence syndrome following chronic administration of delta-9-tetrahydrocannabinol in rhesus monkeys
55. Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity
56. Perceptual masking of drug stimuli
57. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers
58. Discriminative stimulus effects of naltrexone in the morphine-dependent rat
59. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
60. The comparative efficacy of buspirone and diazepam in the treatment of anxiety
61. Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolam
62. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine
63. Development of scales based on patterns of drug effects using the Addiction Research Center Inventory (ARCI)
64. Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model of “fear” motivated behaviour
65. Central nervous system effects of the imidiazodiazepine Ro 15-4513
66. Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazole (PTZ)
67. Anxiety-like subjective effect of ethanol antagonist Ro 15-4513 demonstrated in pentylenetetrazole discrimination
68. Role of benzodiazepine receptors in treatment but not etiology of ethanol-withdrawal anxiety
69. Sensitivity of pentylenetetrazole discrimination increased by a stimulus fading technique
70. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys
71. Hypnotics and sedatives
72. Narcotic discrimination in pigeons
73. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs
74. Discriminative stimulus properties of opioids that interact with mu, kappa and PCP/sigma receptors
75. Operant behavior in the morphine-dependent rhesus monkey
76. Selective antagonists of benzodiazepines
77. A pentylenetetrazol-like stimulus is produced in rats during withdrawal from ingested chlordiazepoxide
78. Opioid analgesics and antagonists
79. Ethanol and Ro 15-4513: behavior maintained by operant procedures (DRL-72s and PTZ-drug discrimination) in rats
80. Assessment of the dependence potential of cocaine in animals
81. The 30-day trip — clinical studies of cannabis tolerance and dependence
82. Tolerance to, and dependence on, some non-opiate psychotropic drugs
83. Rebound insomnia and rebound anxiety: a review
84. Rational use of anxiolytic drugs
85. Behavioral analogs of anxiety: animal models
86. Antagonism of discriminative stimuli produced by anxiogenic drugs as a novel approach to bioassay of anxiolytics
87. Interoceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety
88. Effects of acute and chronic pentylenetetrazole treatment on benzodiazepine and cholinergic receptors binding in rat brain
89. Physiological response to pentylenetetrazol in rats: further evidence for its classification as an anxiogenic drug
90. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal
91. Biogenic monoamine turnover in discrete rat brain regions is correlated with conditioned emotional response and its conditioning history
92. Buspirone-induced jitteriness in three patients with panic disorder and one patient with generalized anxiety disorder
93. Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling
94. Kindling and withdrawal changes at the benzodiazepine receptor
95. Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor
96. Adaptation in neuronal calcium channels as a common basis for physical dependence on central depressant drugs
97. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion
98. Chronic use of benzodiazepines and psychomotor and cognitive test performance
99. Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure
100. Neuropharmacology and neurochemistry of subjective effects, analgesia, tolerance, and dependence produced by narcotic analgesics
101. Pentobarbital blocks the pentylenetetrazol-like effect of withdrawal from chronic diazepam
102. Rebound pentylenetetrazole-substitution by rats after a single large-dose of midazolam
103. The effect of a benzodiazepine antagonist, Ro 15-1788, in diazepam-dependent rats
104. The chlordiazepoxide/pentylenetetrazole discrimination: characterization of drug interactions and homeostatic responses to drug challenges
105. Discriminative response control by naloxone in morphine pretreated rats
106. Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine receptor
107. An evaluation of the elevated plus-maze using the novel anxiolytic buspirone
108. Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study
109. The effects of drugs on barbiturate withdrawal convulsions in the rat
110. Benzodiazepine dependence in the clinic: reason for anxiety?
111. Rapid induction of lorazepam dependence and reversal with flumazenil
112. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states
113. Comparison of the degree of discriminability of various drugs using the t-maze drug discrimination paradigm
114. State dependent learning and drug discriminations
115. Applications and limitations of the drug discrimination method for the study of drug abuse
116. The validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
117. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors
118. Benzodiazepine dependence
119. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine
120. Drugs effective in the therapy of the epilepsies
121. Metrazol tolerance in a ‘normal’ volunteer population
122. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome
123. Variables affecting the self-administration of drugs by rhesus monkeys
124. The discriminative stimulus properties of drugs
125. Self-administration of and behavioral dependence on drugs
126. Behavioral pharmacology of antianxiety drugs
127. Generalization and antagonism studies with convulsant, GABAergic and antioconvulsant drugs in rats trained to discriminate pentylenetetrazol from saline
128. Discriminative stimulus properties of cocaine related to an anxiogenic action
129. Cocaine: recreational use and intoxication
130. Pharmacological conditioning and drug effects
131. Tolerance and selective cross-tolerance to the motivational effects of opioids
132. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity
133. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkey
134. Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys
135. The pharmacology of sedative/hypnotics, alcohol, and anesthetics: sites and mechanisms of action
136. Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines
137. Effects of narcotic abstinence on schedule-controlled behavior in dependent rats
138. β-carbolines can enhance or antagonize the effects of punishment in mice
139. Tolerance for the benzodiazepine diazepam in an animal model of anxiolytic activity
140. Characterisation of agonist, inverse agonist and partial agonist activities of beta-carbolines in a drug discrimination paradigm
141. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors
142. Modulation of anxiety by β-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy
143. Conditioned drug effects on spatial preference: critical evaluation
144. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons
145. Chlordiazepoxide loses its anxiolytic action with long-term treatment
146. The discriminability of naloxone in rats depends on concomitant morphine treatment
147. Behavioral and neurochemical studies on the anticonflict actions of buspirone
148. N-Allylnormorphine: effects of single doses and precipitation of acute “abstinence syndromes” during addiction to morphine, methadone or heroin in man (post-addicts)
149. The role of instrumental learning in behavioral tolerance to drugs
150. Characteristics of tolerance, recovery from tolerance, and cross-tolerance to cocaine used as a discriminative stimulus
151. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine
152. Interoceptive stimuli produced by cocaine are blocked during diazepam withdrawal
153. A pentyleneterazol-like stimulus during cocaine withdrawal: blockade by diazepam and not haloperidol
154. Abuse liability of benzodiazepines
155. Evidence for cocaine dependence in monkeys following a prolonged period of exposure
156. Tolerance to drug discriminative stimuli
157. Discriminative stimulus properties of amphetamine and structurally related phenylalkylamines